Tag: niraparib abiraterone approval

Home / niraparib abiraterone approval

Categories

Niraparib and abiraterone acetate plus prednisone is approved by FDA for BRCA-mutated metastatic castration-resistant prostate cancer

August 2023: The fixed dose combination of niraparib and abiraterone acetate (Akeega, Janssen Biotech, Inc.), along with prednisone, has been approved by the Food and Drug Administration for adult pa...
niraparib-abiraterone-approval

Scan the code